BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Su JS, Chen YT, Wang RC, Wu CY, Lee SW, Lee TY. Clinicopathological characteristics in the differential diagnosis of hepatoid adenocarcinoma: A literature review. World J Gastroenterol 2013; 19(3): 321-327 [PMID: 23372352 DOI: 10.3748/wjg.v19.i3.321] [Cited by in CrossRef: 89] [Cited by in F6Publishing: 74] [Article Influence: 9.9] [Reference Citation Analysis]
Number Citing Articles
1 Kashani A, Ellis JC, Kahn M, Jamil LH. Liver metastasis from hepatoid adenocarcinoma of the esophagus mimicking hepatocellular carcinoma. Gastroenterol Rep (Oxf). 2017;5:67-71. [PMID: 26094198 DOI: 10.1093/gastro/gov021] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
2 Wang YK, Shen L, Jiao X, Zhang XT. Predictive and prognostic value of serum AFP level and its dynamic changes in advanced gastric cancer patients with elevated serum AFP. World J Gastroenterol 2018; 24(2): 266-273 [PMID: 29375212 DOI: 10.3748/wjg.v24.i2.266] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 10] [Article Influence: 2.3] [Reference Citation Analysis]
3 Okura K, Esaki M, Nara S, Ban D, Takamoto T, Shimada K, Hiraoka N. Hepatoid carcinoma and related entities of the extrahepatic bile duct: A clinicopathological study of four cases. Pathol Int 2022. [PMID: 35472251 DOI: 10.1111/pin.13226] [Reference Citation Analysis]
4 Armaghani A, Hernandez Gonzalo D, Daily K. Hepatoid adenocarcinoma of the colon. BMJ Case Rep. 2015;2015. [PMID: 25883249 DOI: 10.1136/bcr-2014-206222] [Cited by in Crossref: 6] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
5 Xia R, Zhou Y, Wang Y, Yuan J, Ma X. Hepatoid Adenocarcinoma of the Stomach: Current Perspectives and New Developments. Front Oncol 2021;11:633916. [PMID: 33912455 DOI: 10.3389/fonc.2021.633916] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Shim J, Go H, Lim YS, Moon KC, Ro JY, Cho YM. Hepatoid differentiation in renal cell carcinoma: a rare histologic pattern with clinical significance. Ann Diagn Pathol 2014;18:363-8. [PMID: 25438926 DOI: 10.1016/j.anndiagpath.2014.10.004] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
7 Velut G, Mary F, Wind P, Aparicio T. Adjuvant chemotherapy by FOLFOX for gastric hepatoid adenocarcinoma. Dig Liver Dis 2014;46:1135-6. [PMID: 25179158 DOI: 10.1016/j.dld.2014.08.036] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
8 Akturk G, Sagol O, Unek T, Ozbilgin M, Egeli T, Karademir S, Obuz F, Astarcioglu IK. Alpha-Fetoprotein-Secreting Gallbladder Carcinoma: a Case Report. J Gastrointest Cancer 2018;49:528-31. [PMID: 28462448 DOI: 10.1007/s12029-017-9950-9] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
9 Lew DH, Jung WT, Kim HJ, Min HJ, Ha CY, Kim HJ, Kim TH, Ko GH. [Clinicopathological characteristics and prognosis of alpha-fetoprotein producing gastric cancer]. Korean J Gastroenterol 2013;62:327-35. [PMID: 24365731 DOI: 10.4166/kjg.2013.62.6.327] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
10 Hu N, Tan Y, Luo J, Cheng Z, Wang Y. 18F-FDG PET/CT of Primary Mediastinal Hepatoid Adenocarcinoma. Clinical Nuclear Medicine 2016;41:321-2. [DOI: 10.1097/rlu.0000000000001150] [Cited by in Crossref: 4] [Article Influence: 0.7] [Reference Citation Analysis]
11 Ni JY, Sun HL, Chen YT, Luo JH, Chen D, Jiang XY, Xu LF. Prognostic factors for survival after transarterial chemoembolization combined with microwave ablation for hepatocellular carcinoma. World J Gastroenterol 2014; 20(46): 17483-17490 [PMID: 25516662 DOI: 10.3748/wjg.v20.i46.17483] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 18] [Article Influence: 2.1] [Reference Citation Analysis]
12 Kogiso T, Sagawa T, Kotera Y, Egawa H, Yamamoto M, Tokushige K. Elevated α-Fetoprotein in the Absence of Carcinoma Caused by Relapse of Hepatitis C Viral Infection after Liver Transplantation. ACG Case Rep J 2018;5:e103. [PMID: 30643846 DOI: 10.14309/crj.2018.103] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
13 Yao ZH, Ke EM, Chen YH, Liu J. One case of hepatoid adenocarcinoma, a rare subtype of gastric cancer. Shijie Huaren Xiaohua Zazhi 2016; 24(7): 1141-1144 [DOI: 10.11569/wcjd.v24.i7.1141] [Reference Citation Analysis]
14 Zhao M, Sun L, Lai JZ, Shi H, Mei K, He X, Jin X, Lai J, Cao D. Expression of RNA-binding protein LIN28 in classic gastric hepatoid carcinomas, gastric fetal type gastrointestinal adenocarcinomas, and hepatocellular carcinomas: An immunohistochemical study with comparison to SALL4, alpha-fetoprotein, glypican-3, and Hep Par1. Pathol Res Pract 2018;214:1707-12. [PMID: 30196987 DOI: 10.1016/j.prp.2018.07.037] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
15 Ranceva A, Stulpinas R, Norvilas R, Mickys U. Hepatoid adenocarcinoma of the stomach with PIK3Ca mutation during pregnancy: A case report with molecular profile. Oxf Med Case Reports 2021;2021:omab078. [PMID: 34527251 DOI: 10.1093/omcr/omab078] [Reference Citation Analysis]
16 Miao RL, Wu AW. Towards personalized perioperative treatment for advanced gastric cancer. World J Gastroenterol 2014; 20(33): 11586-11594 [PMID: 25206266 DOI: 10.3748/wjg.v20.i33.11586] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 17] [Article Influence: 2.1] [Reference Citation Analysis]
17 Jeong JS, Kang HJ, Jo U, Song MJ, Nam SY, Song JS. Hepatoid thymic carcinoma: a case report of a rare subtype of thymic carcinoma. J Pathol Transl Med 2021;55:230-4. [PMID: 33845553 DOI: 10.4132/jptm.2021.03.10] [Reference Citation Analysis]
18 Ji X, Dong H, Dong A. FDG PET/CT of Hepatoid Adenocarcinoma of the Gallbladder. Clin Nucl Med 2020;45:927-8. [PMID: 32910054 DOI: 10.1097/RLU.0000000000003259] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
19 Veerankutty FH, Yeldho V, Tu SA, Venugopal B, Manoj KS, Vidhya C. Hepatoid carcinoma of the pancreas combined with serous cystadenoma: a case report and review of the literature. Hepatobiliary Surg Nutr. 2015;4:354-362. [PMID: 26605284 DOI: 10.3978/j.issn.2304-3881.2015.05.02] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
20 Zhuansun Y, Bian L, Zhao Z, Du Y, Chen R, Lin L, Li J. Clinical characteristics of Hepatoid adenocarcinoma of the lung: Four case reports and literature review. Cancer Treat Res Commun 2021;29:100474. [PMID: 34656923 DOI: 10.1016/j.ctarc.2021.100474] [Reference Citation Analysis]
21 Liu XM, Chen GQ, Li SL, Zai TS. Hepatoid adenocarcinoma of the stomach: A case report and literature review. Exp Ther Med. 2015;9:2133-2136. [PMID: 26136947 DOI: 10.3892/etm.2015.2393] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
22 Zeng SX, Tan SW, Fong CJTH, Liang Q, Zhao BL, Liu K, Guo JX, Tao J. Hepatoid carcinoma of the pancreas: A case report and review of the literature. World J Clin Cases 2020; 8(6): 1116-1128 [PMID: 32258082 DOI: 10.12998/wjcc.v8.i6.1116] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
23 Zeng XY, Yin YP, Xiao H, Zhang P, He J, Liu WZ, Gao JB, Shuai XM, Wang GB, Wu XL, Tao KX. Clinicopathological Characteristics and Prognosis of Hepatoid Adenocarcinoma of the Stomach: Evaluation of a Pooled Case Series. Curr Med Sci. 2018;38:1054-1061. [PMID: 30536069 DOI: 10.1007/s11596-018-1983-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
24 Becq A, Mateescu C, Khayat D, Bouattour M. Atypical Presentation of Hepatocellular Carcinoma Mimicking a Gastric Hepatoid Adenocarcinoma: A Case Report. Medicine (Baltimore) 2015;94:e1101. [PMID: 26166099 DOI: 10.1097/MD.0000000000001101] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
25 Naffouje SA, Anderson RR, Salti GI. A case report of Hepatoid Carcinoma of the Ovary with peritoneal metastases treated with cytoreductive surgery and hyperthermic intraoperative intraperitoneal chemotherapy without systemic adjuvant therapy. Int J Surg Case Rep 2016;27:83-6. [PMID: 27567979 DOI: 10.1016/j.ijscr.2016.08.020] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
26 Randolph LK, Hopkins MK, Hopkins MP, Wasdahl DA. Hepatoid carcinoma of the ovary: A case report and review of the literature. Gynecol Oncol Rep 2015;13:64-7. [PMID: 26425726 DOI: 10.1016/j.gore.2015.06.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 11] [Article Influence: 2.6] [Reference Citation Analysis]
27 . Primary Hepatoid Adenocarcinoma of the Lung: A Study of Two Cases with Review of Literature. Indian Journal of Medical and Paediatric Oncology 2021;41:591-5. [DOI: 10.4103/ijmpo.ijmpo_245_19] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
28 Liu Y, Zhou R, Wang S, Zhang G. Extra-Hepatic Hepatoid Carcinomas in Female Reproductive System: Three Case-Reports with a Literature Review. Cancer Manag Res 2021;13:1625-36. [PMID: 33628053 DOI: 10.2147/CMAR.S288913] [Reference Citation Analysis]
29 Chaudhari R, Murphy K, Schwartz S, Chaudhari J, Ho I, Nunes F. Hepatoid Adenocarcinoma Presenting as Pancreatitis. ACG Case Rep J 2020;7:e00381. [PMID: 32607381 DOI: 10.14309/crj.0000000000000381] [Reference Citation Analysis]
30 Wang Y, Shen L, Lu M, Ji Z, Zhang X. Multimodality Treatment Including Triplet Regimen as First-Line Chemotherapy May Improve Prognosis of Serum AFP-Elevated Gastric Cancer with Liver Metastasis. Gastroenterol Res Pract 2017;2017:5080361. [PMID: 29434637 DOI: 10.1155/2017/5080361] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
31 Arora K, Bal M, Shih A, Moy A, Zukerberg L, Brown I, Liu X, Kelly P, Oliva E, Mullen J. Fetal-type gastrointestinal adenocarcinoma: a morphologically distinct entity with unfavourable prognosis. J Clin Pathol. 2017; Epub ahead of print. [PMID: 28814568 DOI: 10.1136/jclinpath-2017-204535] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
32 Lee DH, Kim SH, Joo I, Han JK. CT Perfusion evaluation of gastric cancer: correlation with histologic type. Eur Radiol 2018;28:487-95. [PMID: 28779403 DOI: 10.1007/s00330-017-4979-5] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
33 Sun JN, Zhang BL, Li LK, Yu HY, Wang B. Hepatoid adenocarcinoma of the lung without production of α-fetoprotein: A case report and review of the literature. Oncol Lett 2016;12:189-94. [PMID: 27347123 DOI: 10.3892/ol.2016.4559] [Cited by in Crossref: 14] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
34 Ye MF, Tao F, Liu F, Sun AJ. Hepatoid adenocarcinoma of the stomach: A report of three cases. World J Gastroenterol 2013; 19(27): 4437-4442 [PMID: 23885160 DOI: 10.3748/wjg.v19.i27.4437] [Cited by in CrossRef: 22] [Cited by in F6Publishing: 20] [Article Influence: 2.4] [Reference Citation Analysis]
35 Søreide JA, Greve OJ, Gudlaugsson E, Størset S. Hepatoid adenocarcinoma of the stomach--proper identification and treatment remain a challenge. Scand J Gastroenterol. 2016;51:646-653. [PMID: 26728165 DOI: 10.3109/00365521.2015.1124286] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 1.5] [Reference Citation Analysis]
36 Díaz-González Á, Monclús E, Darnell A, Solé M, Bruix J. Liver Metastases From Gastric Adenocarcinoma Mimicking Multinodular Hepatocellular Carcinoma. Hepatology 2018;68:2042-4. [PMID: 30044003 DOI: 10.1002/hep.30120] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
37 Li W, Li Q, Yu Y, Wang Y, Chen E, Chen L, Wang Z, Cui Y, Liu T. Effect of Immune Checkpoint Inhibitors Plus Chemotherapy on Advanced Gastric Cancer Patients with Elevated Serum AFP or Hepatoid Adenocarcinoma. Cancer Manag Res 2020;12:11113-9. [PMID: 33173344 DOI: 10.2147/CMAR.S276969] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
38 Wang B, Du C, Li L, Xie Y, Hu C, Li Z, Zhu Y, Yuan Y, Liu X, Lu N, Xue L. New substituted molecular classifications of advanced gastric adenocarcinoma: characteristics and probable treatment strategies. Journal of the National Cancer Center 2021. [DOI: 10.1016/j.jncc.2021.11.004] [Reference Citation Analysis]
39 Berlth F, Bollschweiler E, Drebber U, Hoelscher AH, Moenig S. Pathohistological classification systems in gastric cancer: Diagnostic relevance and prognostic value. World J Gastroenterol 2014; 20(19): 5679-5684 [PMID: 24914328 DOI: 10.3748/wjg.v20.i19.5679] [Cited by in CrossRef: 71] [Cited by in F6Publishing: 64] [Article Influence: 8.9] [Reference Citation Analysis]
40 Devi NR, Sathyalakshmi R, Devi J, Lilly SM. Hepatoid Adenocarcinoma of the Gall Bladder-A Rare Variant. J Clin Diagn Res 2015;9:ED09-10. [PMID: 26435955 DOI: 10.7860/JCDR/2015/10799.6324] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 0.1] [Reference Citation Analysis]
41 Fu Y, Zhu H, Peng WJ. Gastric Hepatoid Adenocarcinoma: Differentiation From Gastric Adenocarcinoma With Dynamic Contrast-Enhanced Computed Tomographic Findings. J Comput Assist Tomogr 2019;43:887-91. [PMID: 31490893 DOI: 10.1097/RCT.0000000000000924] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
42 Wang B, Xie Y, Zheng L, Zheng X, Gao J, Liu X, Yuan Y, Li Z, Lu N, Xue L. Both the serum AFP test and AFP/GPC3/SALL4 immunohistochemistry are beneficial for predicting the prognosis of gastric adenocarcinoma. BMC Gastroenterol 2021;21:408. [PMID: 34706681 DOI: 10.1186/s12876-021-01986-0] [Reference Citation Analysis]
43 Chen X, Li A, Wang Q, Shen Y, Li Z, Peng J, Hu D. Hepatoid adenocarcinoma in the peritoneal cavity: Two case reports. Medicine (Baltimore) 2019;98:e14226. [PMID: 30702578 DOI: 10.1097/MD.0000000000014226] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
44 Zhou RU, Cai Y, Yang YI, Xiang J, Chen Z. Hepatoid adenocarcinoma of the stomach: A case report and review of the literature. Oncol Lett. 2015;9:2126-2128. [PMID: 26137025 DOI: 10.3892/ol.2015.2979] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
45 Lu J, Jin M, Zhou X, Chen X, Shao Y, Jiang X. Clinicopathological and molecular characteristics of the alpha-fetoprotein-producing gastric cancer: emphasis on two major subtypes. APMIS 2021. [PMID: 34862662 DOI: 10.1111/apm.13196] [Reference Citation Analysis]
46 Levy AN, Ackerman R, Yilmaz O, Jouhourian C, Tandon M, Winter MW. Hepatoid Adenocarcinoma of the Rectum With Liver Metastasis in a Patient With Ulcerative Colitis. ACG Case Rep J 2019;6:e00084. [PMID: 31616755 DOI: 10.14309/crj.0000000000000084] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
47 Zeng X, Zhang P, Xiao H, Wu X, Liu W, He J, Gao J, Wang G, Shuai X, Tao K. Clinicopathological features and prognosis of intestinal hepatoid adenocarcinoma: evaluation of a pooled case series. Oncotarget 2018;9:2715-25. [PMID: 29416804 DOI: 10.18632/oncotarget.23595] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
48 Xiao C, Wu F, Jiang H, Teng L, Song F, Wang Q, Yang H. Hepatoid adenocarcinoma of the stomach: Nine case reports and treatment outcomes. Oncol Lett. 2015;10:1605-1609. [PMID: 26622718 DOI: 10.3892/ol.2015.3430] [Cited by in Crossref: 16] [Cited by in F6Publishing: 19] [Article Influence: 2.3] [Reference Citation Analysis]
49 Hu M, Liu W, Yin F, Zhang D, Liu X, Lai J. Liver Metastasis of Hepatoid Colonic Adenocarcinoma: A Rare and Unusual Entity With Poor Prognosis and Review of the Literature. Gastroenterology Res 2018;11:430-5. [PMID: 30627268 DOI: 10.14740/gr1097] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
50 Arif D, Mettler T, Adeyi OA. Mimics of hepatocellular carcinoma: a review and an approach to avoiding histopathological diagnostic missteps. Hum Pathol 2021;112:116-27. [PMID: 33346018 DOI: 10.1016/j.humpath.2020.12.002] [Reference Citation Analysis]
51 Zeremski V, Mawrin C, Fischer T, Schalk E. Diagnostic and therapeutic challenges in extragonadal yolk sac tumor with hepatoid differentiation: A case report. Mol Clin Oncol 2017;6:79-82. [PMID: 28123734 DOI: 10.3892/mco.2016.1080] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
52 Trinh HS, Luong TH, Lai TT, Nguyen TK. Mixed pancreatic hepatoid carcinoma: A surgical case report and literature review. Int J Surg Case Rep 2021;83:105951. [PMID: 33971555 DOI: 10.1016/j.ijscr.2021.105951] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Inayat F, Zafar F, Lodhi HT, Ullah W. Primary peritoneal hepatoid adenocarcinoma: a diagnostic and therapeutic conundrum in patients with gastrointestinal bleeding. BMJ Case Rep 2018;2018:bcr-2018-226938. [PMID: 30232078 DOI: 10.1136/bcr-2018-226938] [Reference Citation Analysis]
54 de Velde AV, De Moor N, Meyskens T, Bempt IV, Christiaens M, Schöffski P. Case report: Hepatoid adenocarcinoma of soft tissue. Current Problems in Cancer: Case Reports 2022;5:100134. [DOI: 10.1016/j.cpccr.2021.100134] [Reference Citation Analysis]
55 Choi WT, Ramachandran R, Kakar S. Immunohistochemical approach for the diagnosis of a liver mass on small biopsy specimens. Hum Pathol. 2017;63:1-13. [PMID: 28087475 DOI: 10.1016/j.humpath.2016.12.025] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 4.2] [Reference Citation Analysis]
56 Cheng CY, Wu IC, Chen YT, Hu HM. A rare hepatoid adenocarcinoma from the gastric remnant. Kaohsiung J Med Sci. 2016;32:482-483. [PMID: 27638409 DOI: 10.1016/j.kjms.2016.04.012] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
57 Chandan VS, Shah SS, Torbenson MS, Wu T. Arginase-1 is frequently positive in hepatoid adenocarcinomas. Human Pathology 2016;55:11-6. [DOI: 10.1016/j.humpath.2016.04.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 3.3] [Reference Citation Analysis]
58 Sun Y, Chang W, Yao J, Liu H, Zhang X, Wang W, Zhao K. Effect of immune checkpoint inhibitors in patients with gastric hepatoid adenocarcinoma: a case report and literature review. J Int Med Res 2022;50:3000605221091095. [PMID: 35469480 DOI: 10.1177/03000605221091095] [Reference Citation Analysis]
59 Chang MY, Kim HJ, Park SH, Kim H, Choi DK, Lim JS, Park MS, Kim MJ, Kim H. CT features of hepatic metastases from hepatoid adenocarcinoma. Abdom Radiol (NY) 2017;42:2402-9. [PMID: 28421242 DOI: 10.1007/s00261-017-1150-3] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
60 Osada M, Aishima S, Hirahashi M, Takizawa N, Takahashi S, Nakamura K, Tanaka M, Maehara Y, Takayanagi R, Oda Y. Combination of hepatocellular markers is useful for prognostication in gastric hepatoid adenocarcinoma. Hum Pathol. 2014;45:1243-1250. [PMID: 24767858 DOI: 10.1016/j.humpath.2014.02.003] [Cited by in Crossref: 28] [Cited by in F6Publishing: 25] [Article Influence: 3.5] [Reference Citation Analysis]
61 Li M, Fan Y, Lu H. Hepatoid Adenocarcinoma of the Lung. Technol Cancer Res Treat 2021;20:15330338211057983. [PMID: 34816785 DOI: 10.1177/15330338211057983] [Reference Citation Analysis]
62 Chen Y, Schaeffer DF, Yoshida EM. Hepatoid adenocarcinoma of the colon in a patient with inflammatory bowel disease. World J Gastroenterol 2014; 20(35): 12657-12661 [PMID: 25253971 DOI: 10.3748/wjg.v20.i35.12657] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 9] [Article Influence: 0.5] [Reference Citation Analysis]
63 Levi Sandri GB, Carboni F, Covello R, Valle M, Garofalo A. Liver nodule occurrence in chronic liver disease: HCC unique option? Clin Res Hepatol Gastroenterol. 2014;38:3-4. [PMID: 23867549 DOI: 10.1016/j.clinre.2013.06.002] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
64 Yin H, Hu Y, Xiu Y, Luo R, Shi H. A Rare Case of Primary Endometrial Hepatoid Adenocarcinoma on 18F-FDG PET/CT. Clin Nucl Med 2019;44:e425-7. [DOI: 10.1097/rlu.0000000000002538] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
65 Wei J, Xue Y, Huo X, Han R, Su X, Jin Y, Zhao W, Chen Y, Zhang H, Dai J, Chen J. Establishment and characterization of the GC-030-35 cell line derived from gastric hepatoid adenocarcinoma. Cancer Manag Res 2019;11:1275-87. [PMID: 30799954 DOI: 10.2147/CMAR.S186416] [Reference Citation Analysis]
66 Thambamroong T, Prasongsook N, Satayasoontorn K, Saichaemchan S. Extremely high alpha-fetoprotein-producing adrenal hepatoid adenocarcinoma. BMJ Case Rep 2021;14:e239830. [PMID: 34253511 DOI: 10.1136/bcr-2020-239830] [Reference Citation Analysis]
67 Li J, Liu Y, Xu JH, Xu ZP, Zheng S, Ding KF. Expression of hepatocyte growth factor and c-Met is characteristic of α-fetoprotein-producing colorectal adenocarcinoma: A report of three cases. Oncol Lett 2016;11:731-4. [PMID: 26870275 DOI: 10.3892/ol.2015.3964] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.1] [Reference Citation Analysis]
68 Shi YF, Lu JG, Yang QM, Duan J, Lei YM, Zhao W, Liu YQ. Primary hepatoid adenocarcinoma of the lung in Yungui Plateau, China: A case report. World J Clin Cases 2019; 7(13): 1711-1716 [PMID: 31367631 DOI: 10.12998/wjcc.v7.i13.1711] [Cited by in CrossRef: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
69 Lin YY, Chen CM, Huang YH, Lin CY, Chu SY, Hsu MY, Pan KT, Tseng JH. Liver metastasis from hepatoid adenocarcinoma of the stomach mimicking hepatocellular carcinoma: Dynamic computed tomography findings. World J Gastroenterol 2015; 21(48): 13524-13531 [PMID: 26730164 DOI: 10.3748/wjg.v21.i48.13524] [Cited by in CrossRef: 8] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
70 Søreide JA. Therapeutic Approaches to Gastric Hepatoid Adenocarcinoma: Current Perspectives. Ther Clin Risk Manag 2019;15:1469-77. [PMID: 31920320 DOI: 10.2147/TCRM.S204303] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
71 Reis H, Padden J, Ahrens M, Pütter C, Bertram S, Pott LL, Reis AC, Weber F, Juntermanns B, Hoffmann AC, Eisenacher M, Schlaak JF, Canbay A, Meyer HE, Sitek B, Baba HA. Differential proteomic and tissue expression analyses identify valuable diagnostic biomarkers of hepatocellular differentiation and hepatoid adenocarcinomas. Pathology 2015;47:543-50. [PMID: 26308133 DOI: 10.1097/PAT.0000000000000298] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.8] [Reference Citation Analysis]
72 Lin JX, Wang ZK, Hong QQ, Zhang P, Zhang ZZ, He L, Wang Q, Shang L, Wang LJ, Sun YF, Li ZX, Liu JJ, Ding FH, Lin ED, Fu YA, Lin SM, Xie JW, Li P, Zheng CH, Huang CM. Assessment of Clinicopathological Characteristics and Development of an Individualized Prognostic Model for Patients With Hepatoid Adenocarcinoma of the Stomach. JAMA Netw Open 2021;4:e2128217. [PMID: 34609494 DOI: 10.1001/jamanetworkopen.2021.28217] [Reference Citation Analysis]
73 Remo A, Fassan M, Vanoli A, Bonetti LR, Barresi V, Tatangelo F, Gafà R, Giordano G, Pancione M, Grillo F, Mastracci L. Morphology and Molecular Features of Rare Colorectal Carcinoma Histotypes. Cancers (Basel) 2019;11:E1036. [PMID: 31340478 DOI: 10.3390/cancers11071036] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 6.0] [Reference Citation Analysis]
74 Wang XY, Bao WQ, Hua FC, Zuo CT, Guan YH, Zhao J. AFP-producing hepatoid adenocarcinoma of appendix: a case report of 18F-FDG PET/CT. Clin Imaging 2014;38:526-8. [PMID: 24721022 DOI: 10.1016/j.clinimag.2014.02.019] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
75 Malya FU, Bozkurt S, Hasbahceci M, Cipe G, Ahmad IC, Gucin Z, Karatepe O, Muslumanoglu M. A rare tumor in a patient with hepatic hydatic cyst: adrenal hepatoid adenocarcinoma. Case Rep Med 2014;2014:824574. [PMID: 24715921 DOI: 10.1155/2014/824574] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
76 Ip S, Schaeffer DF, Yoshida EM, Kwan WP. Alpha Fetoprotein-Secreting Gastric Cancer in the Setting of Chronic Hepatitis B: The Role of Endoscopy. ACG Case Rep J 2015;2:152-4. [PMID: 26157947 DOI: 10.14309/crj.2015.38] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
77 Zhang HZ, Wang SY. AFP-producing Xp11 translocation renal cell carcinoma: Case report and review of the literature. Curr Probl Cancer 2021;45:100689. [PMID: 33388149 DOI: 10.1016/j.currproblcancer.2020.100689] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
78 Chang JM, Katariya NN, Lam-Himlin DM, Haakinson DJ, Ramanathan RK, Halfdanarson TR, Borad MJ, Pannala R, Faigel D, Moss AA, Mathur AK. Hepatoid Carcinoma of the Pancreas: Case Report, Next-Generation Tumor Profiling, and Literature Review. Case Rep Gastroenterol 2016;10:605-12. [PMID: 27920649 DOI: 10.1159/000448064] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
79 Jin R, Yu Q, Liang X. Ectopic hepatocellular carcinoma manifesting multiple abdominal masses: A case report. Medicine (Baltimore). 2017;96:e8968. [PMID: 29310401 DOI: 10.1097/md.0000000000008968] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
80 Liu Z, Wang A, Pu Y, Li Z, Xue R, Zhang C, Xiang X, E JY, Bu Z, Bai F, Ji J. Genomic and transcriptomic profiling of hepatoid adenocarcinoma of the stomach. Oncogene 2021. [PMID: 34326469 DOI: 10.1038/s41388-021-01976-2] [Reference Citation Analysis]
81 Tsuruta S, Ohishi Y, Fujiwara M, Ihara E, Ogawa Y, Oki E, Nakamura M, Oda Y. Gastric hepatoid adenocarcinomas are a genetically heterogenous group; most tumors show chromosomal instability, but MSI tumors do exist. Hum Pathol 2019;88:27-38. [PMID: 30946937 DOI: 10.1016/j.humpath.2019.03.006] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
82 Lei L, Yang L, Xu YY, Chen HF, Zhan P, Wang WX, Xu CW. Hepatoid adenocarcinoma of the lung: An analysis of the Surveillance, Epidemiology, and End Results (SEER) database. Open Med (Wars) 2021;16:169-74. [PMID: 33585692 DOI: 10.1515/med-2021-0215] [Reference Citation Analysis]
83 Yang J, Wang R, Zhang W, Zhuang W, Wang M, Tang C. Clinicopathological and prognostic characteristics of hepatoid adenocarcinoma of the stomach. Gastroenterol Res Pract. 2014;2014:140587. [PMID: 24669215 DOI: 10.1155/2014/140587] [Cited by in Crossref: 11] [Cited by in F6Publishing: 16] [Article Influence: 1.4] [Reference Citation Analysis]